- Home
- SLQT vs ORIC Comparison
SLQT vs ORIC Comparison
Compare SLQT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- ORIC
- Stock Information
- Founded
- SLQT 1999
- ORIC 2014
- Country
- SLQT United States
- ORIC United States
- Employees
- SLQT N/A
- ORIC N/A
- Industry
- SLQT Specialty Insurers
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- ORIC Health Care
- Exchange
- SLQT Nasdaq
- ORIC Nasdaq
- Market Cap
- SLQT 386.9M
- ORIC 362.9M
- IPO Year
- SLQT 2020
- ORIC 2020
- Fundamental
- Price
- SLQT $2.39
- ORIC $10.50
- Analyst Decision
- SLQT Hold
- ORIC Strong Buy
- Analyst Count
- SLQT 2
- ORIC 8
- Target Price
- SLQT $3.38
- ORIC $18.83
- AVG Volume (30 Days)
- SLQT 898.0K
- ORIC 1.1M
- Earning Date
- SLQT 05-12-2025
- ORIC 08-11-2025
- Dividend Yield
- SLQT N/A
- ORIC N/A
- EPS Growth
- SLQT N/A
- ORIC N/A
- EPS
- SLQT N/A
- ORIC N/A
- Revenue
- SLQT $1,488,701,000.00
- ORIC N/A
- Revenue This Year
- SLQT $17.72
- ORIC N/A
- Revenue Next Year
- SLQT $13.05
- ORIC N/A
- P/E Ratio
- SLQT N/A
- ORIC N/A
- Revenue Growth
- SLQT 20.41
- ORIC N/A
- 52 Week Low
- SLQT $1.62
- ORIC $3.90
- 52 Week High
- SLQT $6.86
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- SLQT 54.86
- ORIC 70.83
- Support Level
- SLQT $2.25
- ORIC $9.80
- Resistance Level
- SLQT $2.53
- ORIC $11.19
- Average True Range (ATR)
- SLQT 0.10
- ORIC 0.61
- MACD
- SLQT 0.04
- ORIC -0.04
- Stochastic Oscillator
- SLQT 73.47
- ORIC 81.20
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.